The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE) Study - a Randomized Controlled Trial
Latest Information Update: 23 May 2022
At a glance
- Drugs Influenza virus RIV4 vaccine-(FluBlok Quadrivalent) (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Acronyms DRIVE
- 16 May 2022 Status changed from recruiting to active, no longer recruiting.
- 24 Jun 2021 Planned number of patients changed from 820 to 1103.
- 24 Jun 2021 Planned End Date changed from 31 Dec 2024 to 31 Dec 2025.